Funding, deals, hiring, trials and approvals across biotech, pharma and academia — plus the newest papers in virology, molecular biology, cell biology, NGS, oncology and veterinary medicine, ranked by journal tier and topical fit.
A standing roster of biopharma and life-science tooling companies — 18 tracked.
Merck (MRK) Stock May Be 37% Undervalued On Fresh FDA Approval
Yahoo Finance · 2026-09-26
Merck Animal Health talks flea, tick prevention | PA Live! – 28/22 News
28/22 News · 2026-09-26
Merck & Co., Daiichi withdraw US submission for ADC in lung cancer
FirstWord · 2026-09-26
Boehringer Ingelheim offloads Shanghai CDMO to local antibody developer
Fierce Pharma · 2026-09-24
Lexeo takes up the Mantle in $8M acquisition for Friedreich ataxia assets
Fierce Biotech · 2026-09-22
Novartis secures new radioligand in $900M deal as competition strengthens
Fierce Biotech · 2026-09-22
Analysts ‘extremely bullish’ as Telix beams into Novartis’ territory with $1.6B ITM acquisition
Fierce Biotech · 2026-09-21
Mirum bags FDA approval for ultra-rare bone lesion disorder, heating up rivalry with Regeneron
Fierce Pharma · 2026-09-25
Mount Sinai Researchers Receive $3.6 Million NIH Grant to Improve Mitral Valve Surgery Decisions | Newswise
Newswise · 2026-09-22
Also watching, nothing this window: Azenta Life Sciences, Humane Genomics, Pfizer, Thermo Fisher, GenScript, UCB, Immunai, Genmab, Insmed, Evotec, Kenvue, Rocket Pharmaceuticals
Highest-scoring work indexed this window, one per field.
| Virology | |
| Molecular Biology | |
| Cell Biology | |
| NGS / Genomics | |
| Oncology | |
| Veterinary Medicine |
Ordered by how many independent outlets ran the story
US FDA approves Lilly's once-weekly insulin injection for type 2 diabetes Reuters
FDA Approves Belzutifan Plus Lenvatinib for Advanced Renal Cell Carcinoma After Immunotherapy Pharmacy Times
The next Alnylam? RNAi biotech City Therapeutics files for IPO Endpoints News
Fredun Pharmaceuticals acquires 26% stake in Rs. 300 crore valued Goodman Vetcare Indian Pharma Post
FDA Approves Lirafugratinib for Previously Treated, Unresectable, Locally Advanced or Metastatic Cholangiocarcinoma The ASCO Post
FDA approves Lilly's Olumiant (baricitinib) for pediatric patients 12 years of age and older with severe alopecia areata Eli Lilly
ADARx Pharmaceuticals raises $446.3 million in upsized US IPO Yahoo Finance Singapore
FDA Approves Lirafugratinib Capsules for FGFR2+ Cholangiocarcinoma Care Oncology Nursing News
Nvidia, QIA-backed Iambic Therapeutics files for US IPO as biotech boom rolls on By Reuters Investing.com
Drug developer ADARx seeks $1.74 billion valuation in US IPO Reuters
Financings, IPOs, venture rounds
Nvidia-backed Iambic files for IPO, disclosing new clinic and dealmaking details Endpoints News
Axio BioPharma raises $2.4M to link pharma manufacturing data across companies Dealroom.co
Retension and Lilly-backed TRex Bio both set out plans to join biotech IPO stampede Fierce Biotech
Enveda, an AI drugmaker, banks $311M in venture funding BioPharma Dive
Enveda reaps $311M series E to feed ambition to become a ‘household name’ Fierce Biotech
M&A, licensing, reverse mergers
Telix to Buy ITM in $1.65B Radiopharma Deal Contract Pharma
Grünenthal acquires cancer treatment Stivarga thepharmaletter.com
Telix ITM merger to build radiopharmaceutical powerhouse Voice of Healthcare
Delhi-Based Jagsonpal Pharma to Acquire Group Pharmaceuticals' Wellness Portfolio for Up to Rs 46.7 Crore Medical Dialogues
Analysts ‘extremely bullish’ as Telix beams into Novartis’ territory with $1.6B ITM acquisition Fierce Biotech
Hires, exits, layoffs, restructurings
aTyr Pharma announces alignment with FDA on Phase 3 study of efzofitimod TipRanks
ImmunoScape Appoints Peter Olagunju as Chief Executive Officer Business Wire
Engitix appoints Sonia Quaratino as EVP Chief Medical Officer PMLiVE
Diageo Appoints WPP’s Joanne Wilson As Chief Financial Officer DirectorsTalk Interviews
Bliss GVS Pharma appoints Rahul Adakmol as Chief Executive Officer scanx.trade
Readouts, starts, failures
Positive Phase 2 Topline Results: Remlifanserin for the Treatment of Alzheimer Disease Psychosis Psychiatric Times
Rise Therapeutics Completes Dose Escalation in R-5780 Phase 1 Cancer Trial, Advances to Dose Expansion PR Newswire
New Preliminary Positive Data From Open-Label Extension of Phase 3 Study: Fasedienol for the Acute Treatment of Social Anxiety Disorder Psychiatric Times
U.S. FDA Approves Update to the Label for WINREVAIR™ (sotatercept-csrk) to Include Data from the Phase 3 HYPERION Trial Evaluating Adults Recently Diagnosed with Pulmonary Arterial Hypertension (PAH, WHO* Group 1 Pulmonary Hypert
Roche Obesity Drug Enicepatide Delivers 15.5% Weight Loss in Phase 2 Diabetes Trial Yahoo Finance
Approvals, CRLs, CHMP opinions
Elevar wins first FDA approval with second-line drug for bile duct cancer Endpoints News
FDA Approves Efsitora Once-Weekly Basal Insulin Injection Medscape
FDA Approves Onswik for Adults with Type 2 Diabetes Pharmaceutical Executive
Mirum bags FDA approval for ultra-rare bone lesion disorder, heating up rivalry with Regeneron Fierce Pharma
Study unveils ‘plug-and-play’ CAR T technology designed to adapt as cancer changes eurekalert.org
Grants, budgets, institutions
White House plans to put NIH grants under political control: reports Fierce Biotech
Reports: Trump Wants More Control Over NIH Funding Inside Higher Ed
UH Manoa secures $5.9M NIH grant to expand Maui wildfire study Hawaii News Now
These 6 charts show how NIH research funding has been reshaped under Trump NPR
NGS, virology and animal-health industry moves
New research shows genetic changes were behind the Kent meningitis outbreak Meningitis Now
A Common Virus Shows Signs of Reactivating Up to 3 Months Before a Multiple Sclerosis Attack ScienceAlert
Elanco Animal Health (ELAN) CEO adds 126 deferred stock units Stock Titan
Animal use in veterinary vaccines quality control falls to lowest levels in a decade gov.uk
Elanco Animal Health Eyes Growth, Deleveraging as Quattro and Zenrelia Gain Ground Yahoo Finance